baber/WOPTO huggingface dataset:
Patent IL-205674-A0 (IL)
Title: Method and apparatus for secured facsimile transmission
Filed: 2010-05-11
Abstract: The present invention relates to a method for secured facsimile transmission of a document, comprising the steps of generating at least one image of said document (step a)), reading the pixels of said at least one image into a series of blocks of predetermined size (step b)), converting said series of blocks into a character string based on a conversion table (step c)), encrypting said character string to create an encrypted character string (step d)), compressing said encrypted character string to create a scrambled image (step e)), and transmitting said scrambled image (step f )), wherein an option between a standard encryption mode and an optimized encryption mode is provided, wherein in the standard encryption mode in step a) one image is generated from the entire document and in the optimized encryption mode in step a) a series of images is generated, each image corresponding to one line of the document, in step b) the pixels of each image of said series of images are read into a series of blocks of predetermined size, in step c) said series of blocks corresponding to each image are each converted into a character string, resulting in one character string per image, and in step d) only character strings corresponding to images with at least one non- white pixel are encrypted. The present invention relates further to an apparatus for performing the method of the invention.
Patent RO-127940-A0 (RO)
Title: Multicontact suction electrode for biosignal sampling
Inventor: LOSONCZI LAJOS
IPC: A61B5/04
Filed: 2012-03-12
Abstract: The invention relates to a suction electrode which can be fixed onto a biological surface, such as human skin, to allow the electrical sampling of biosignals which are then further transmitted to be processed. According to the invention, the electrode consists of an enclosure () closed by a resilient membrane () mounted in contact with a spring () wherein a negative pressure can be created by suction and discharge valves (), respectively, in order to allow some metal contacts () to be perfectly attached onto a biological surface, thereby making possible the biosignal sampling.
Patent RO-135720-A0 (RO)
Title: Metal- and zeolite-based catalysts with reverse network structure, method for producing it and uses thereof
Inventor: DAVID ELENA
IPC: B01J29/40
Filed: 2021-12-06
Abstract: The invention relates to mesoporous zeolytic catalysts of the Me/MFI type with the active metal component Co, to a method for their preparation as well as to a process for using these catalysts for the production of bio-oil with a high content of aliphatic and aromatic hydrocarbons. According to the invention, the catalysts consist of a mesoporous zeolite with a reverse network structure MFI, with an average mesopore size of between 2 and 5 nm, with a pore distribution ranging between 1 and 1.5 nm in width, determined at half height, with a surface area between 472...546 m2/g, with an average pore volume between 0.1...1.0 cm2/g, having an average volume of micropores between 0.05...0.2 cm3/g and metals charged in the zeolite mass. According to the invention, the method of preparation consists in mixing the polymers D400 and D4000 at a temperature between 80...100°C, in a concentration of 0.025...0.1 mg/l with glycidoxy-propyl-silane GOPTMS, while maintaining the temperature for 24 hours, preparation of the silane mesoporogen MPOS and its functionalization, crystallization of the zeolitic phase, washing the resulting zeolitic material MFI with ethanol, drying it in air and calcinating at 600°C, for 4 hours, protonation by treating the calcined zeolite with a solution of 10% ammonium nitrate at 80°C for 12 hours, calcinating the protonated zeolite in air at 500°C, for 4 hours, followed by impregnation thereof with a 5% aqueous solution of the metal precursor Co(NO3)2.6H2O, calcination in air at 500°C, for 4 hours, step followed by reduction at 500°C with a mixture of 10% H2 in argon, for 4 hours, and preparation of the Co/MFI catalyst. According to the invention, the process consists in impregnating 1 g of catalyst with 1 ml of aqueous solution Co(NO3)2. 6H2 for 6 hours, at room temperature, the charged amount of Co being between 0.5...3.5%.
Patent LU-84104-A1 (LU)
Inventor: GEORGES MATHGEN
IPC: H05B7/12
Filed: 1982-04-22
Abstract: A seal for use around a rod electrode passing along an axis through a hole in the wall of a furnace into the interior of the furnace has an annular and at least limitedly flexible seal ring fitted snugly around the electrode in the hole and a holder carrying the seal ring and sealingly engaged with the furnace wall. Thus gas flow through the wall at the hole past the seal ring is substantially blocked. The seal assembly has structure forming with the electrode and seal ring a substantially closed chamber surrounding the electrode axially inward into the furnace from the ring. This chamber is pressurized at superatmospheric pressure with an inert gas and the electrode is cooled inward of the furnace from the seal ring. The seal ring is compressed axially by a packing assembly so it is pressed radially against the electrode. The packing includes rigid split compression rings bearing axially on the seal ring.
Patent MA-23204-A1 (MA)
Inventor: BERNARD CAPON
IPC: B01D24/12
Filed: 1994-05-25
Abstract: Filtering device for the clarification of liquids, especially of industrial or effluent water, of the type comprising an open tank provided with a floor with nozzles supporting the filter bed, side chutes for the delivery of the raw water, a gutter for discharging filtered water, means for lifting the material from the filter and an axial gutter for discharging the washing water, this device being characterised in that the bottom of the filter, under the floor (12) is separated along its lengthwise axis by a leakproof partition (20) bounding two independent cells (14, 15 - 14' - 15') in the filter.
Patent MA-25749-A1 (MA)
Inventor: PLATRE DAVID
IPC: B65D51/20
Filed: 2002-11-14
Abstract: The invention concerns a method which consists in mounting a ring or rigid peripheral base (7) designed to be closed by a sealing and tight inner seal (8) at the circumference of the end part (10) of said container or said package, designed to form an opening to provide access to the content or for emptying same. Said ring can receive a moulded or clipped on cover on one of its edges. The invention also concerns the container provided with said closure member.
Patent MA-26308-A1 (MA)
Inventor: TIMP PIET HEIM WILLEM
IPC: B67D1/04
Filed: 2002-12-09
Abstract: The application relates to an assembly comprising a container (1) for drink provided at a top (2) with a beverage outlet (4) situated on a centre line, which outlet (4) is connectable to a flexible dispensing line (5) having an outlet end (6), and with a pressure inlet (20) situated at a distance from the centre line for receiving a pressure medium into the container, wherein the assembly comprises a bridge (33) formed as an integral unit, the bridge being attachable to the container (1) at the top (2), the bridge having a gas channel with on one side a connector (48) for attaching to a pressure medium source and on the other side to the pressure inlet of the container, and having an opening for guiding an operating element (51) that is attached to an inflow end of the dispensing line (5), in the direction of the outlet (4) for opening of the outlet.
Patent MA-27855-A1 (MA)
Title: Composition contenant un inhibiteur de pde4 et un inhibiteur de pde5
Inventor: DUNKERN THORSTEN
IPC: A61K31/522
Filed: 2005-12-12
Abstract: Abstrait L'invention concerne l'administration combinée de l'inhibiteur PDE4 et de l'inhibiteur PDE5 pour le traitement de la maladie dans laquelle l'activité de la phosphodiestérase 4 (PDE4) et/ou de la phosphodiestérase 5 (PDE5) est nuisible.
Patent MA-37444-A1 (MA)
Title: Utilisation intra-utérine de 18-méthyl-15 bêta, 16-bêta-méthylène-19-nor-20-spirox-4-en-3-ones, système intra-utérin contenant du 18-méthyl-15 bêta, 16-bêta-méthylène-19-nor-20-spirox-4-en-3-ones, et utilisation desdits composés pour la contraception et les traitements gynécologiques
Inventor: NUBBEMEYER REINHARD
IPC: A61P15/18
Filed: 2014-10-21
Abstract: L'invention concerne l'utilisation intra-utérine de 18-méthyl-15 bêta, 16-bêta-méthylène-19-nor-20-spirox-4-en-3-ones de la formule générale (1) pour la contraception et les traitements gynécologiques. L'invention concerne également un système intra-utérin contenant les composés de la formule (1).
Patent MA-37811-A1 (MA)
Title: Solution d'acétaminophène injectable sursaturée pour l'administration spinale
Inventor: MITIDIERI AUGUSTO
IPC: A61P29/00
Filed: 2015-01-27
Abstract: La présente invention concerne une solution aqueuse injectable d'acétaminophène à utiliser dans le traitement ou dans la prévention de la douleur par administration spinale, ladite solution injectable d'acétaminophène étant sursaturée. Dans certains modes de réalisation, la solution aqueuse injectable d'acétaminophène est administrée simultanément, séparément ou séquentiellement avec un anesthésique local par administration spinale.
Patent MA-39157-A1 (MA)
Title: Composition utile pour favoriser la fertilite feminine
Inventor: VIRMANI ASHRAF
IPC: A61K33/34
Filed: 2014-11-13
Abstract: La présente invention concerne une composition synergique pour favoriser la fertilité féminine, comportant en tant que principes actifs la l-carnitine, l'acétyle l-carnitine; la n-acétyle cystéine, et diverses vitamines spécifiques, des aminoacides, des antioxydants et des microéléments.
Patent MA-39177-A1 (MA)
Title: Correction d'erreurs avec test de plusieurs longueurs pour une trame de données
Inventor: DORNSTETTER JEAN LOUIS
IPC: H03M13/45
Filed: 2016-07-11
Abstract: Procédé de réception de trames de données dans lequel on détermine une trame de référence par décisions fermes sur la valeur de chaque bit reçu et on procède à une vérification de la trame de référence suivant un codage de contrôle d'intégrité utilisé pour la transmission. Selon l'invention : - on calcule, pour chaque bit de ladite trame de référence, une valeur de vraisemblance représentative de la probabilité d'erreur de transmission; et, en cas d'incompatibilité avec ledit codage de contrôle d'intégrité : - on identifie dans ladite trame de référence un ensemble fini non vide de bits les plus vraisemblablement erronés en fonction desdites valeurs de vraisemblance; - on énumère des trames candidates correspondant chacune respectivement à l'une des combinaisons possibles de nombre d'inversions des bits les plus vraisemblablement erronés identifiés; - on vérifie la compatibilité des trames candidates énumérées avec ledit codage de contrôle d'intégrité.
Patent MA-40819-A1 (MA)
Title: Variant d'arni
Inventor: O'RIORDAN CATHERINE
IPC: C12N15/113
Filed: 2016-02-09
Abstract: La présente invention concerne des molécules d'arni comprenant un premier brin contenant une séquence de guidage et un second brin comprenant une séquence qui n'est pas une séquence de guidage, la séquence qui n'est pas une séquence de guidage contenant un renflement à l'opposé de la région d'ensemencement des séquences de guidage ; p. Ex., à l'opposé de la séquence de clivage. Selon certains aspects, l'invention concerne un arni destiné à traiter la maladie de huntington. L'invention concerne en outre de
Patent UY-24935-A1 (UY)
Title: Antagonistas del receptor de vitronectina
Inventor: MILLER WILLIAM HENRY
IPC: A61K33/243
Filed: 1998-03-25
Abstract: Compuestos derivados de benzacepina, antagonistas del receptor de la vitronectina y que son útiles en el tratamiento de la osteoporosis y para fabricación de medicamentos destinados a inhibición de tumores, tratamiento de arteriosclerosis, reesterosis o inflamaciones. Se trata de compuestos de fórmula l (como por ejemplo: ácido (+-)-6-[3-(2-piridilamino)-1-propiloxi]-3-oxo-2,3,4,5-tetrahidro-1H-2-benzazepina-4-acético), en donde R1 significa alquilo A-C0-4, opcionalmente sustituido por cualquiera accesible de uno o más de R10 o R7; y R2 es un compuesto de fórmula ll; o una sal farmacéuticamente aceptable del mismo. Una composición farmacéutica que comprende un compuesto de fórmula l y un agente antineoplásico y un vehiculo farmacéuticamente aceptable.
Patent UY-25150-A1 (UY)
Title: Derivados de la n-aroilfenilalanina
Inventor: TILLEY JEFFERSON WRIGHT
IPC: C07C323/60
Filed: 1998-08-21
Abstract: Se describen compuestos de fórmula I los cuales tienen actividad como inhibidores de la unión entre la VCAM - 1 y las células que expresan la VLA - 4. Dichos compuestos son de utilidad para el tratamiento de enfermedades cuyos síntomas y/o lesiones están relacionados con la unión de la VCAM - 1 a las células que expresan la VLA - 4. Se trata de compuestos de fórmula l (como por ejemplo: 4-[[(2,6-diclorofenil)carbonil]amino]-N-[[1-[(4-metoxifenil)metil]ciclopentil]carbonil]-L-fenilalanina), en donde uno de X y X' son H, halogeno o alquilo inferior y el otro es un grupo de fórmula ll; Y es un grupo de fórmula lll; Z se selecciona entre H o alquilo inferior; y las sales farmacéuticamente aceptables de los mismos. Compuestos de fórmula l para emplear como medicamento en el tratamiento de artritis reumatoide, esclerosis múltiple, enfermedad inflamatoria del intestino o asma.
Patent UY-27027-A1 (UY)
Title: Kit de repinotano
Inventor: KROLL DR WERNER
IPC: G01N33/94
Filed: 2001-11-19
Abstract: La invención trata de kit que incluye una composición farmacéutica, que contiene repinotano o una sal fisiológicamente inofensiva de repinotano, y un medio para determinar la concentración de repinotano o sus metabolitos en líquidos corporales, así como nuevas composiciones farmacéuticas, que contienen repinotano o una sal fisiológicamente inofensiva de repinotano, y procedimientos para la preparación de éstos.
Patent UY-28518-A1 (UY)
Title: Derivados de quinazolina
Inventor: HENNEQUIN LAURENT FRANCOIS AND
Filed: 2004-09-16
Abstract: La invención se refiere a derivados de quinazolina de fórmula I: en donde los sustituyentes son como se definen en el texto para su uso en la producción de un efecto anti-proliferativo el cual se produce solamente, o en parte, por la inhibición del receptor tirosina quinasa de erbB2 en un animal de sangre caliente como el hombre.
Patent UY-30037-A1 (UY)
Title: Uso de derivados heterociclicos benzo-fusionados de sulfamida para modificacion de la enfermedad/epileptogenesis
Inventor: SMITH-SWINTOSKY VIRGINIA L
IPC: C07D307/00
Filed: 2006-12-19
Abstract: La presente invención es un método para tratar, prevenir, revertir, detener o inhibir la ocurrencia, el desarrollo y la maduración de convulsiones o trastornos relacionados con las convulsiones. De un modo más específico, la presente invención se refiere a métodos para le uso de derivados heterocíclicos benzofusionados de sulfamida de fórmula (I) y fórmula (II) como se describe aquí para tratar, prevenir, revertir, detener o inhibir en forma terapéutica o profiláctica la epileptogénesis y epilepsia.
Patent AT-500459-A1 (AT)
IPC: B01L3/14
Filed: 2004-01-23
Abstract: Assembling a cap (20) of the closure device (9), having an open end, of a receiving vessel (5) so as to form a receptor device (1) for body fluids or tissue parts or cultures, comprising making a rotational or revolving movement, between (20) and (5), relative to the common longitudinal axis, is new. Assembling a cap (20) of the closure device (9), having an open end, of a receiving vessel (5) so as to form a receptor device (1) for body fluids or tissue parts or cultures, by making a rotational or revolving movement, between (20) and (5), relative to the common longitudinal axis. To provide the relative movement, a force (F), directed close to the axis (14), is applied to at least one of (5) and (20). Independent claims are also included for: (1) cap (20) for use in the process; (2) receiving vessel (5) for use in the process; and (3) receptor device (1) comprising at least one cap (20), a sealing device (21) included in (20), and (5).
Patent ES-165029-A1 (ES)
Title: PROCEDIMIENTO PARA LA PREPARACIoN DE PRODUCTOS DE CONDENSACIoN
Filed: 1944-03-04
Abstract: Procedimiento para la preparación de productos de condensación caracterizado porque se condensan nitroetanoles arílicos con compuestos que contienen hidrógeno sustituible.
Patent ES-173066-A1 (ES)
Title: UN PROCEDIMIENTO PARA LA OBTENCIoN DE COMPUESTOS DE FUMIGACIoN
IPC: A01N25/20
Filed: 1946-03-30
Abstract: Procedimiento apra la obtención de compuestos de fumigación caracterizándose por la preparación de una mezcla que comprende un compuesto de fumigación que se evapora en caliente nitrato amónico y un cromato sensible al nitrato amónico en cantidad suficiente apra hacer que la composición pueda propagar por toda ella a una presión atmosférica corriente una reacción exotérmica cuando se inicie el calentamiento local.
Patent ES-177277-A1 (ES)
Title: UN APARATO DE ILUMINACIoN INDIRECTA
Filed: 1947-03-18
Abstract: Aparato de iluminación indirecta, caracterizado porque comporta un disco cóncavo cuya parte central está arrollada hacia abajo en medio bocel y que contiene la fuente o fuentes luminosas, tapándolas a la vista.
Patent ES-181422-A1 (ES)
Title: Un dispositivo tractor accionado eléctricamente.
Filed: 1947-12-31
Abstract: Un dispositivo tractor accionado eléctricamente en el cual dicho dispositivo está destinado a avanzar sobre una sola oruga sin fin en la que va montado el motor y mediante la cual es transmitida la fuerza motriz.
Patent ES-183576-A1 (ES)
Title: SOPORTE PERFECCIONADO PARA ELEMENTO DE CANAL, TUBERiA U OTRA PIEZA
IPC: F16L3/12
Filed: 1948-05-05
Abstract: Soporte perfeccionado para elemento de canal al descubierto, tubos y otros elementos que se caracteriza porque comprende en combinación un pie o soporte propiamente dicho y un dispositivo de calce móvil en la cara superior del mencionado pie, para poder hacer un reglaje del elemento soportado, transversalmente y/o en altura.
Patent ES-196800-A1 (ES)
Title: Un perfeccionamiento en la construccion de cascos secadores del cabello
Filed: 1951-02-22
Abstract: Perfeccionamiento en la construcción de cascos secadores del cabello que esencialmente consiste en disponer un interruptor basculante preferentemente de mercurio a la entrada general del circuito eléctrico que automáticamente cierre el circuito de alimentación al colocarse el casco en posición de uso y deje dicho circuito abierto al levantarse el caso y quedar con su eje próximo a la horizontal.
Patent ES-262953-A1 (ES)
Title: Improvements relating to metal-containing reactive azo dyestuffs containing pyrimidylamino groups and their use
IPC: C09B62/032
Filed: 1960-12-03
Abstract: The invention comprises dyestuffs corresponding to the general formula <FORM:0961552/C4-C5/1> wherein Z represents hydrogen, chlorine or bromine, X represents hydrogen, chlorine, bromine, the nitro, cyano, acyl, alkyl or phenyl group, Hal means chlorine or bromine, R represents hydrogen or an alkyl group having 1 to 4 carbon atoms, A represents a possibly further substituted phenylene radical which is bound to the oxygen atom in o-position to the azo linkage, B represents a possibly further substituted naphthylene radical which is bound to the oxygen atom in o-position to the azo-linkage, Me represents a heavy metal of atomic number 24 to 29 or a complex of said heavy metal with other complex formers and n represents a positive whole number from 1 to 5. The dyes are produced by reacting a pyrimidine compound containing chlorine or bromine in the 2- and 4-positions, the substituent X in the 5-position and the substituent Z in the 6-position with an appropriate metallized aminobenzene azo naphthalene dye in the presence of an acid binding agent or by metallizing an appropriate azo dye with an agent providing heavy metal of atomic number 24 to 29. The dyes are suitable for printing or dyeing cellulosic and polyamidic materials. Metals specified include chromium, cobalt, nickel and copper. Substituents which may be present in diazo and coupling components include halogen, cyano, alkyl, alkoxy, sulphonic acid, sulphonic amide or ester, carboxylic acid and amide and nitro groups. Preferred dyes contain the pyrimidylamino group in o- or p-position to the oxygen atom in radical A and a sulphonic group in the p- or o-position to the oxygen atom. Further preferred dyes contain the pyrimidylamino group in the p-position to the azo linkage optionally with a substituent present in p-position to the oxygen atom, e.g. halogen or an alkyl, alkysulphonyl or sulphonic group. Examples are furnished.
Patent ES-266536-A1 (ES)
Title: Ceramic pigments
IPC: C09C1/00
Filed: 1961-04-13
Abstract: A ceramic pigment consists essentially of calcined oxides of zirconium, silicon and iron, the whole or the major portion of which are associated together in the form of an ironcontaining zircon crystal lattice. The admixture of the oxides or oxide producing compounds of Zr, Si and Fe is calcined with compounds giving a source of alkali metal ions, a source of fluoride ions and preferably also a source of halide ions selected from bromide and chloride ions. The percentages by weight of the pigment are ZrO2 35 to 80 SiO2 10 to 55 Fe2O3 0.1 to 10 alkali metal ions (Na and K used) 0.25 to 8.0 fluoride ions 0.25 to 3.0 chloride or bromide ions 0.25 to 8.0. The calcination temperature is 700 DEG C. to 1100 DEG C.
Patent ES-290019-A1 (ES)
Title: Plastic laminates
IPC: B32B27/00
Filed: 1963-07-15
Abstract: A laminate comprises a film of a non-polyolefinic thermoplastic material such as vinylidene chloride-acrylonitrile copolymer, a film of polypropylene and a film of another polyolefin such as polyethylene. The surface of the polypropylene or polyethylene may be treated to improve adhesion, e.g. by electrical discharge or chemical means. The films may be bonded together by adhesives such as cellulose esters and ethers, alkyl and acrylic esters, polyamides, polyesters, polystyrene, synthetic rubbers, polyvinyl alcohol, epoxy resins and urea-, phenol-, or melamine - formaldehyde resins. The laminate is made by first applying the thermoplastic to the polypropylene as a coating, a pre-formed film or by extrusion and then passing the thermoplastic-polypropylene laminate with the polythene film through heated rollers. The polypropylene and polyethylene films may contain opacifiers, stabilizers, lubricants, fillers and organic or inorganic pigments.
Patent ES-293748-A1 (ES)
Title: Servo steering of vehicles
IPC: F15B9/12
Filed: 1963-11-22
Abstract: A servo-steering system of a vehicle comprises a fixed steering housing 8a servo-cylinder (29) operatively connected by a piston (22), with a rod (21) on one side only, to steering mechanism coupled to the steerable wheels of the vehicle, a distributer valve 20 for distributing pressure fluid to the cylinder controlled by a manual steering control including first and second coaxial shafts 1 and 4 which are rotatably coupled with angular free play, as by pin-and-slot connection 18/19, and which each present a guideway 14, (16), (Fig. 3, not shown), which guideways are inclined one to the other and into which extend a pin 12 so that on relative rotation of the shafts 1 and 4 the pin 12 is displaced axially of the shafts operating a slidable valve spool 7 of the distributer to which the pin is connected by a rod 10, located within shaft 4, and a ball-and-socket connection 9. The distributer valve 20 constantly connects pressure fluid inlet 51 through valve passages 50 and 42 and valve annulus 47 and annular passage 38 of the servo-cylinder with chamber (34), (Fig. 2, not shown), on the piston-rod (21) side of piston (22) and selectively connects chamber (35) on the other side of the piston (22) with inlet 51 through valve passages 50 and 44, and annulus 47 and passage (36) of the servo-cylinder or with fluid outlet 49 through passages (36), 43, 44 and 48. As shown, piston-rod (21) is coupled to the rack (2) of rack-and-pinion steering mechanism 2, 3.